| RS397514643 |
WNT7A
|
Health Risk |
Pathogenic |
Schinzel phocomelia syndrome, Schinzel phocomelia syndrome |
| RS397514644 |
AKT1
|
Health Risk |
Pathogenic |
Cowden syndrome 6, Cowden syndrome 6 |
| RS397514645 |
AKT1
|
Health Risk |
Pathogenic |
Cowden syndrome 6, Cowden syndrome 6 |
| RS397514646 |
EIF2B5
|
Health Risk |
Pathogenic |
Leukoencephalopathy with vanishing white matter 5, Leukoencephalopathy with vanishing white matter 5 |
| RS397514647 |
EIF2B3
|
Health Risk |
Pathogenic |
Leukoencephalopathy with vanishing white matter 3, Leukoencephalopathy with vanishing white matter 3 |
| RS397514648 |
EIF2B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of the nervous system, Leukoencephalopathy with vanishing white matter 2 |
| RS397514649 |
DLD
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Lactic acidosis |
| RS397514650 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS397514651 |
DLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS397514652 |
ALDH1A3
|
Health Risk |
Pathogenic |
Isolated microphthalmia 8, Isolated microphthalmia 8 |
| RS397514653 |
ALDH1A3
|
Health Risk |
Pathogenic |
Isolated microphthalmia 8, Isolated microphthalmia 8 |
| RS397514654 |
HK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4G, Hemolytic anemia due to hexokinase deficiency |
| RS397514655 |
MEF2C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS397514656 |
MEF2C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS397514657 |
SLC52A2
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 2, Brown-Vialetto-van Laere syndrome 2 |
| RS397514659 |
POLG2
|
Health Risk |
Pathogenic |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 |
| RS397514660 |
CTC1
|
Health Risk |
Pathogenic |
Cerebroretinal microangiopathy with calcifications and cysts 1, Dyskeratosis congenita |
| RS397514661 |
EPCAM
|
Health Risk |
Pathogenic |
Congenital diarrhea 5 with tufting enteropathy, Gastric cancer |
| RS397514662 |
COX15
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardioencephalomyopathy, fatal infantile |
| RS397514663 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS397514664 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS397514665 |
LRP5
|
Health Risk |
Pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS397514666 |
WNT7A
|
Health Risk |
Pathogenic |
Schinzel phocomelia syndrome, Schinzel phocomelia syndrome |
| RS397514667 |
CD27
|
Health Risk |
Pathogenic |
Lymphoproliferative syndrome 2, Lymphoproliferative syndrome 2 |
| RS397514668 |
GDF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Type A2 brachydactyly, Grebe syndrome |
| RS397514669 |
UBIAD1
|
Health Risk |
Likely pathogenic |
Schnyder crystalline corneal dystrophy, Schnyder crystalline corneal dystrophy |
| RS397514670 |
SYNGAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS397514671 |
STIM1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to STIM1 deficiency, Stormorken syndrome |
| RS397514672 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS397514673 |
KCNJ10
|
Health Risk |
Conflicting classifications of pathogenicity |
EAST syndrome, Inborn genetic diseases |
| RS397514674 |
FKBP10
|
Health Risk |
Pathogenic/Likely pathogenic |
Bruck syndrome 1, Osteogenesis imperfecta type 11 |
| RS397514675 |
STIM1
|
Health Risk |
Likely pathogenic |
Myopathy, tubular aggregate |
| RS397514676 |
STIM1
|
Health Risk |
Pathogenic |
Myopathy, tubular aggregate |
| RS397514677 |
STIM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, tubular aggregate |
| RS397514678 |
JAM3
|
Health Risk |
Likely pathogenic |
Porencephaly-microcephaly-bilateral congenital cataract syndrome, Porencephaly-microcephaly-bilateral congenital cataract syndrome |
| RS397514679 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS397514681 |
SAG
|
Health Risk |
Pathogenic |
Oguchi disease, Oguchi disease-1 |
| RS397514682 |
SAG
|
Health Risk |
Pathogenic |
Oguchi disease, Retinitis pigmentosa 47 |
| RS397514683 |
EFEMP2
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal recessive |
| RS397514684 |
MLH1
|
Health Risk |
Likely pathogenic |
Mismatch repair cancer syndrome 1, Hereditary cancer-predisposing syndrome |
| RS397514685 |
IL21R
|
Health Risk |
Pathogenic |
Cryptosporidiosis-chronic cholangitis-liver disease syndrome, Cryptosporidiosis-chronic cholangitis-liver disease syndrome |
| RS397514686 |
CARD11
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CARD11 deficiency, Severe combined immunodeficiency due to CARD11 deficiency |
| RS397514687 |
AGTR1
|
Health Risk |
Likely pathogenic |
Renal tubular dysgenesis, Essential hypertension |
| RS397514688 |
ACE
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular dysgenesis, Abnormality of prenatal development or birth |
| RS397514689 |
ACE
|
Health Risk |
Pathogenic |
Renal tubular dysgenesis, Microvascular complications of diabetes |
| RS397514690 |
REN
|
Health Risk |
Pathogenic |
Renal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2 |
| RS397514691 |
REN
|
Health Risk |
Pathogenic |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS397514692 |
NLRP1
|
Health Risk |
Pathogenic |
Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome, Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome |
| RS397514693 |
CSNK1D
|
Health Risk |
Pathogenic |
Advanced sleep phase syndrome 2, Advanced sleep phase syndrome 2 |
| RS397514694 |
PRKN
|
Health Risk |
Pathogenic |
Autosomal recessive juvenile Parkinson disease 2, Autosomal recessive juvenile Parkinson disease 2 |
| RS397514695 |
RXYLT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS397514696 |
RXYLT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS397514697 |
STAMBP
|
Health Risk |
Pathogenic |
Microcephaly-capillary malformation syndrome, Microcephaly-capillary malformation syndrome |
| RS397514698 |
GNAQ
|
Health Risk |
Pathogenic |
Capillary malformation, Sturge-Weber syndrome |
| RS397514700 |
ANTXR1
|
Health Risk |
Pathogenic/Likely pathogenic |
GAPO syndrome, GAPO syndrome |
| RS397514701 |
ANTXR1
|
Health Risk |
Pathogenic |
GAPO syndrome, GAPO syndrome |
| RS397514702 |
WNT1
|
Health Risk |
risk factor |
OSTEOPOROSIS, EARLY-ONSET |
| RS397514703 |
GJA3
|
Health Risk |
Likely pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS397514705 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS397514706 |
CHST14
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, musculocontractural type 1 |
| RS397514707 |
FIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Yunis-Varon syndrome, Amyotrophic lateral sclerosis |
| RS397514708 |
GATM
|
Health Risk |
Pathogenic |
Arginine:glycine amidinotransferase deficiency, Fanconi renotubular syndrome 1 |
| RS397514709 |
GATM
|
Health Risk |
Likely pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS397514710 |
IRF8
|
Health Risk |
Pathogenic |
Immunodeficiency 32B, Immunodeficiency 32B |
| RS397514711 |
IRF8
|
Health Risk |
Likely pathogenic |
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency, Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency |
| RS397514712 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS397514713 |
TBC1D24
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 16 |
| RS397514714 |
TBC1D24
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 16 |
| RS397514716 |
SMAD9
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS397514717 |
B3GALT6
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloepimetaphyseal dysplasia with joint laxity, type 1 |
| RS397514718 |
B3GALT6
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia with joint laxity, type 1 |
| RS397514719 |
B3GALT6
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia with joint laxity, type 1 |
| RS397514720 |
B3GALT6
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia with joint laxity, type 1 |
| RS397514721 |
B3GALT6
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, spondylodysplastic type |
| RS397514723 |
B3GALT6
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia with joint laxity, type 1 |
| RS397514724 |
B3GALT6
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia with joint laxity, type 1 |
| RS397514725 |
GDF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 17, Klippel-Feil syndrome 1 |
| RS397514726 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome 3, Joubert syndrome 3 |
| RS397514727 |
COQ2
|
Health Risk |
risk factor |
Multiple system atrophy, Multiple system atrophy |
| RS397514728 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS397514729 |
CASR
|
Health Risk |
Pathogenic |
Bartter syndrome with hypocalcemia, Bartter syndrome with hypocalcemia |
| RS397514730 |
ALAS2
|
Health Risk |
Pathogenic |
X-linked erythropoietic protoporphyria, X-linked erythropoietic protoporphyria |
| RS397514731 |
CTSF
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 13, Neuronal ceroid lipofuscinosis 13 |
| RS397514732 |
CTSF
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 13, Neuronal ceroid lipofuscinosis 13 |
| RS397514733 |
CTSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 13, Neuronal ceroid lipofuscinosis |
| RS397514734 |
GJC2
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS397514735 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia-cerebral and retinal hemorrhage syndrome, Charcot-Marie-Tooth disease dominant intermediate B |
| RS397514736 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Gnathodiaphyseal dysplasia |
| RS397514737 |
GABRG2
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus 3, Self-limited epilepsy with centrotemporal spikes |
| RS397514738 |
SCN8A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS397514739 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS397514740 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS397514741 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS397514742 |
PRDM16
|
Health Risk |
Pathogenic |
Left ventricular noncompaction 8, Left ventricular noncompaction cardiomyopathy |
| RS397514745 |
KARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 89, Nonsyndromic genetic hearing loss |
| RS397514746 |
KARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 89, Autosomal recessive nonsyndromic hearing loss 89 |
| RS397514747 |
DDR2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome, Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome |
| RS397514749 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 5, Inborn genetic diseases |
| RS397514750 |
VLDLR
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS397514751 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, dilated |